{
    "clinical_study": {
        "@rank": "114390", 
        "arm_group": [
            {
                "arm_group_label": "Grp 1 Ropivacaine Block", 
                "arm_group_type": "Active Comparator", 
                "description": "Group 1 consented subjects will receive for their hip arthroscopy procedures general anesthesia (sevoflurane) with single femoral and lateral femoral cutaneous nerve blocks under ultrasound guidance, with 20 ml solution for the femoral block and 10 ml for lateral femoral cutaneous block, for a total of 30 ml solution of ropivacaine  0.5% with epinephrine 1:200,000 (150mcg) as a tracer for intravascular injection (total 30 ml)"
            }, 
            {
                "arm_group_label": "Grp 2 Placebo Block", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Group 2 consented subjects will receive for their hip arthroscopy procedures general anesthesia (sevoflurane) with single femoral and lateral femoral cutaneous nerve blocks under ultrasound guidance, with 20 ml solution for the femoral block and 10 ml for lateral femoral cutaneous block, for a total of 30 ml solution of saline with epinephrine 1:200,000 (150 mcg) (total 30 ml)"
            }
        ], 
        "brief_summary": {
            "textblock": "The goal of the study is to evaluate via a prospective, blinded, randomized clinical trial,\n      whether ultrasound-guided single femoral and lateral femoral cutaneous nerve blocks with\n      ropivacaine 0.5% with epinephrine (1:200,000) as a tracer for intravascular injection (total\n      30 ml) vs. saline with epinephrine (1:200,000) (total 30 ml), given just prior to same day\n      elective hip arthroscopy, is effective in reducing acute postoperative pain (NRS scores),\n      postoperative opiate consumption, and time to discharge from the postanesthesia care unit.\n      Differences between groups with respect to postoperative quality of life and functional\n      scores will also be evaluated."
        }, 
        "brief_title": "Are Preemptive Femoral and Lateral Femoral Cutaneous Nerve Blocks Given Immediately Prior to Hip Arthroscopy Effective for Acute Postoperative Pain Management?", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Internal Derangement of Hip", 
            "Acetabular Labrum Tear"
        ], 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to evaluate whether ultrasound (using sound waves to produce an\n      image)-guided regional anesthesia (local numbing medicine) to the hip area given in addition\n      to general anesthesia just prior to same day elective hip arthroscopy, is effective in\n      reducing acute postoperative pain, and time to discharge from the post anesthesia care unit.\n       In addition, the study aims to examine whether this regional anesthesia medication has any\n      effect on the study subjects' use of pain medication both during and after the procedure,\n      return to function, and quality of life in the 6 month period after the surgical procedure.\n      Although hip arthroscopy is a routine procedure, the best method for pain control is not\n      well established, and is the purpose of this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  >18 year old,\n\n          -  ASA physical status classification system score (ASA) <=3\n\n          -  due to undergo elective unilateral hip arthroscopy by one surgeon Dr. Shane Nho\n             (Co-Principal Investigator)\n\n        Exclusion Criteria:\n\n          -  ASA physical status classification system score) (ASA) >3\n\n          -  history of opioid dependence or abuse\n\n          -  current chronic analgesic therapy (daily use =>20 mg oxycodone-equivalent opioid use\n             within 2 weeks before surgery and duration of use >=4 weeks)\n\n          -  allergy to study medications (fentanyl and ropivicaine)\n\n          -  any neuromuscular deficit of the ipsilateral femoral nerve or quadriceps femoris\n             muscle (including diabetic peripheral neuropathy)\n\n          -  diagnosis of hypertension and/or current treatment for hypertension\n\n          -  pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "3", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01997567", 
            "org_study_id": "Hip-Scope-Block"
        }, 
        "intervention": [
            {
                "arm_group_label": "Grp 1 Ropivacaine Block", 
                "description": "Subjects will receive for their hip arthroscopy procedures general anesthesia (sevoflurane) with single femoral and lateral femoral cutaneous nerve blocks under ultrasound guidance, with 20 ml solution for the femoral block and 10 ml for lateral femoral cutaneous block, for a total of 30 ml solution of ropivacaine 0.5% with epinephrine 1:200,000 (150mcg) as a tracer for intravascular injection (total 30 ml)", 
                "intervention_name": "Ropivacaine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Grp 2 Placebo Block", 
                "description": "Group 2 consented subjects will receive for their hip arthroscopy procedures general anesthesia (sevoflurane) with single femoral and lateral femoral cutaneous nerve blocks under ultrasound guidance, with 20 ml solution for the femoral block and 10 ml for lateral femoral cutaneous block, for a total of 30 ml solution of saline with epinephrine 1:200,000 (150 mcg) (total 30 ml)", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Ropivacaine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hip Arthroscopy", 
            "Regional Anesthesia", 
            "Peripheral Nerve block"
        ], 
        "lastchanged_date": "March 27, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Oak Park", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60304"
                }, 
                "name": "Rush Oak Park Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Are Preemptive Femoral and Lateral Femoral Cutaneous Nerve Blocks Given Immediately Prior to Hip Arthroscopy Effective for Acute Postoperative Pain Management?", 
        "overall_official": [
            {
                "affiliation": "Rush University Medical Center", 
                "last_name": "Sandeep Amin, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Rush University Medical Center", 
                "last_name": "Shane Nho, M.D., M.S.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The primary outcome measure will be pain scores at rest (NRS 0-10). Those scores will be documented at initial visit prior to surgery, and at postoperative office visits at 3 weeks, 3 months and 6 months post-procedure.", 
                "measure": "PAIN NUMERICAL RATING SCALE SCORE (NRS 0-10)", 
                "safety_issue": "No", 
                "time_frame": "Preoperative 2-8 wks"
            }, 
            {
                "description": "The primary outcome measure will be pain scores at rest (NRS 0-10). Those scores will be documented at initial visit prior to surgery, and at postoperative office visits at 3 weeks, 3 months and 6 months post-procedure.", 
                "measure": "PAIN NUMERICAL RATING SCALE SCORE (NRS 0-10)", 
                "safety_issue": "No", 
                "time_frame": "3 wks postoperative"
            }, 
            {
                "description": "The primary outcome measure will be pain scores at rest (NRS 0-10). Those scores will be documented at initial visit prior to surgery, and at postoperative office visits at 3 weeks, 3 months and 6 months post-procedure.", 
                "measure": "PAIN NUMERICAL RATING SCALE SCORE (NRS 0-10)", 
                "safety_issue": "No", 
                "time_frame": "3 months postoperative"
            }, 
            {
                "description": "The primary outcome measure will be pain scores at rest (NRS 0-10). Those scores will be documented at initial visit prior to surgery, and at postoperative office visits at 3 weeks, 3 months and 6 months post-procedure.", 
                "measure": "PAIN NUMERICAL RATING SCALE SCORE (NRS 0-10)", 
                "safety_issue": "No", 
                "time_frame": "6 months postoperative"
            }
        ], 
        "reference": [
            {
                "PMID": "22822195", 
                "citation": "YaDeau JT, Tedore T, Goytizolo EA, Kim DH, Green DS, Westrick A, Fan R, Rade MC, Ranawat AS, Coleman SH, Kelly BT. Lumbar plexus blockade reduces pain after hip arthroscopy: a prospective randomized controlled trial. Anesth Analg. 2012 Oct;115(4):968-72. Epub 2012 Jul 19."
            }, 
            {
                "PMID": "22498045", 
                "citation": "Ward JP, Albert DB, Altman R, Goldstein RY, Cuff G, Youm T. Are femoral nerve blocks effective for early postoperative pain management after hip arthroscopy? Arthroscopy. 2012 Aug;28(8):1064-9. doi: 10.1016/j.arthro.2012.01.003. Epub 2012 Apr 11."
            }, 
            {
                "PMID": "18929290", 
                "citation": "Lee EM, Murphy KP, Ben-David B. Postoperative analgesia for hip arthroscopy: combined L1 and L2 paravertebral blocks. J Clin Anesth. 2008 Sep;20(6):462-5."
            }, 
            {
                "PMID": "18033568", 
                "citation": "Good RP, Snedden MH, Schieber FC, Polachek A. Effects of a preoperative femoral nerve block on pain management and rehabilitation after total knee arthroplasty. Am J Orthop (Belle Mead NJ). 2007 Oct;36(10):554-7."
            }, 
            {
                "PMID": "22965491", 
                "citation": "Aprato A, Jayasekera N, Villar R. Timing in hip arthroscopy: does surgical timing change clinical results? Int Orthop. 2012 Nov;36(11):2231-4. doi: 10.1007/s00264-012-1655-x. Epub 2012 Sep 11."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01997567"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rush University Medical Center", 
            "investigator_full_name": "Sandeep Amin, MD", 
            "investigator_title": "Assistant Professor, Attending Anesthesiologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Preoperative VR-12 scores will be compared with the VR-12 scores obtained at the 3 mo and 6 mo postoperative visits.", 
                "measure": "Veterans RAND 12  Item Health Survey (VR-12) Scores", 
                "safety_issue": "No", 
                "time_frame": "Preoperative 2-8 wks"
            }, 
            {
                "description": "Preoperative VR-12 scores will be compared with the VR-12 scores obtained at the 3 mo and 6 mo postoperative visits.", 
                "measure": "Veterans RAND 12  Item Health Survey (VR-12) Scores", 
                "safety_issue": "No", 
                "time_frame": "3 months postoperative"
            }, 
            {
                "description": "Preoperative VR-12 scores will be compared with the VR-12 scores obtained at the 3 mo and 6 mo postoperative visits.", 
                "measure": "Veterans RAND 12  Item Health Survey (VR-12) Scores", 
                "safety_issue": "No", 
                "time_frame": "6 months postoperative"
            }
        ], 
        "source": "Rush University Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rush University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014", 
        "why_stopped": "Study Surgeon indicates that study subject recruitment is too difficult and he forsees that\n    will not improve, and therefore requested we terminate the study."
    }
}